AstraZeneca Acquires All Rights to Orexo's OX-CLI Project By: Benzinga via Benzinga March 17, 2016 at 09:47 AM EDT Orexo AB (publ) today announced that AstraZeneca (NYSE: AZN) has decided to acquire all rights to the leukotriene C4 synthase inhibitor ... Read More >> Related Stocks: Astrazeneca Plc ADR Macy's